期刊文献+

低钾失盐性肾小管病患者WNK基因突变研究 被引量:1

Mutations of WNK gene in patients with hypokalemic salt-losing tubulopathies
下载PDF
导出
摘要 目的通过对低钾失盐性肾小管病(SLTs)家系WNK基因外显子扩增测序,初步探讨SLTs的分子遗传学机制。方法以经CLCNKB和SLC12A3基因测序不符合典型Bartter综合征或Gitelman综合征基因型的8个SLTs家系为研究对象,抽提患者及患病/非患病亲属的外周血DNA,设计引物扩增WNK4和WNK1的外显子序列,送测序并进行序列比对。结果对8个SLTs家系的WNK基因扫描发现2个WNK1杂合错义突变,分别为Ile1172→Met(I1172M)和Ser2047→Asn(S2047N),且仅存在于家系患病者中,非患病家族成员及正常对照中均未检出。结论在8个SLTs家系患病者中发现2个伴氨基酸改变的WNK1杂合突变(I1172M和S2047N),提示WNK激酶可能是非婴儿期SLTs的第三个致病基因。 Objective To explore the molecular mechanisms involved in hypokalemic salt-losing tubulopathies (SLTs) through genetic screening of WNK gene in patients with SLTs. Methods Forty-four kindreds of SLTs were diagnosed Batter's syndrome or Gitelman's syndrome after CLCNKB and SLC12A3 sequencing and analysis,8 of whose phenotype can not be simply attributed to CLCNKB or SLC12A3 mutations. Primers for PCR-amplified exons of WNK4 and WNK1 gene in genomic DNA were designed,and direct sequencing was performed to analyse the PCR products. Results Two missense mutations of WNK1,Ile 1172→Met (I1172M) and Ser 2047→Asn (S2047N),were identified. Both of these 2 mutations segregated with the disease in SLTs kindred. Conclusion Two heterozygote missense mutations of WNK1 gene (I1172M and S2047N) were found in 8 SLTs kindreds,indicating that WNK1 might be another gene responsible for hypokalemic salt-losing tubulopathies.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2009年第11期1344-1350,共7页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市科委重点项目(07JC14037) 上海市科委重大项目(08dz1900502)~~
关键词 低钾失盐性肾小管病 WNK激酶 突变 测序 hypokalemic salt-losing tubulopathies WNK kinase mutation sequencing
  • 相关文献

参考文献4

二级参考文献59

  • 1徐明彤,丁鹤林,严励,程桦.Gitelman综合征一例报告[J].中华肾脏病杂志,2005,21(1):58-58. 被引量:3
  • 2Bing-eXU,Byung-HoonLEE,XiaoshanMIN,LisaLENERTZ,CharlesJHEISE,SteveSTIPPEC,ElizabethJGOLDSMITH,MelanieH.COBB.WNK1: analysis of protein kinase structure, downstream targets, and potential roles in hypertension[J].Cell Research,2005,15(1):6-10. 被引量:4
  • 3江永娣,傅秀兰,陈楠,董德长,储谦.Bartter综合征的诊断和治疗(附4例报道)[J].中华内分泌代谢杂志,1995,11(1):57-58. 被引量:7
  • 4Chao TH, Hayashi M, Tapping RI, Kato Y, Lee JD. MEKK3directly regulates MEK5 activity as part of thebig mitogen- activated protein kinase 1 (BMK1) signaling pathway. J Biol Chem 1999; 274:36035-8.
  • 5Chayama K, Papst PJ, Garrington TP, et al. Role of MEKK2-MEK5 in the regulation of TNF-alpha gene expression and MEKK2-MKK7 in the activation of c-Jun N-terminal kinase in mast cells. Proc Natl Acad Sci U S A 2001; 98:4599-604.
  • 6Kato Y, Kravchenko VV, Tapping RI, et al. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J 1997; 16:7054-66.
  • 7Kamakura S, Moriguchi T, Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus.J Biol Chem 1999; 274:26563-71.
  • 8Watson FL, Heerssen HM, Bhattacharyya A, et al. Neurotrophins use the Erk5 pathway to mediate a retrograde survival response.Nat Neurosci 2001; 4:981-8.
  • 9Sun W, Kesavan K, Schaefer BC, et al. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. J Biol Chem 2001; 276:5093-100.
  • 10Xu B, Stippec S, Lenertz L, et al. WNK1 activates ERK5 by an MEKK2/3-dependent mechanism. J Biol Chem 2004; 279:7826-31.

共引文献32

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部